PC
COEPW

Periscope Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Periscope Capital’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-88,880
Closed -$3K – 932
2022
Q3 		$3K Hold
88,880
– – ﹤0.01% 1111
2022
Q2 		$4K Hold
88,880
– – ﹤0.01% 1140
2022
Q1 		$7K Hold
88,880
– – ﹤0.01% 1147
2021
Q4 		$29K Hold
88,880
– – ﹤0.01% 948
2021
Q3 		$23K Sell
88,880
-15,000
-14% -$5.7K ﹤0.01% 868
2021
Q2 		$56K Sell
103,880
-27,262
-21% -$13.9K ﹤0.01% 718
2021
Q1 		$59K Buy
+131,142
New +$123K ﹤0.01% 540

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Periscope Capital's COEPW Position: Q4 2022 in Review

Periscope Capital sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2022, closing a stake of 88,880 shares — an estimated $3K sold.

Periscope Capital first reported a position in COEPW in Q1 2021 and held it in 7 quarters. The position peaked at $59K in Q1 2021. 21 funds tracked by Wall St. Rank hold COEPW as of Q4 2022.

  • Periscope Capital reported no remaining Coeptis Therapeutics Warrants position as of Q4 2022 after selling out during the quarter.
  • Periscope Capital sold 88,880 Coeptis Therapeutics Warrants shares in Q4 2022, an estimated $3K.
  • Periscope Capital first reported a position in Coeptis Therapeutics Warrants in Q1 2021 and held it in 7 quarters.
  • Periscope Capital's Coeptis Therapeutics Warrants position peaked at $59K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.